785
Views
19
CrossRef citations to date
0
Altmetric
Reviews

Course of Ocular Function in PRPF31 Retinitis Pigmentosa

, , , &
Pages 49-52 | Accepted 02 Apr 2015, Published online: 09 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kristian Lisbjerg, Mette Bertelsen, Julie Lyng Forman, Karen Grønskov, Josephine Prener Holtan & Line Kessel. (2023) Disease progression of retinitis pigmentosa caused by PRPF31 variants in a Nordic population: a retrospective study with up to 36 years follow-up. Ophthalmic Genetics 44:2, pages 139-146.
Read now
Danial Roshandel, Jennifer A. Thompson, Jason Charng, Dan Zhang, Enid Chelva, Sukanya Arunachalam, Mary S. Attia, Tina M. Lamey, Terri L. McLaren, John N. De Roach, David A. Mackey, Steve D. Wilton, Sue Fletcher, Samuel McLenachan & Fred K. Chen. (2021) Exploring microperimetry and autofluorescence endpoints for monitoring disease progression in PRPF31-associated retinopathy. Ophthalmic Genetics 42:1, pages 1-14.
Read now

Articles from other publishers (17)

Jason Comander, Carol Weigel DiFranco, Kit Sanderson, Emily Place, Matthew Maher, Erin Zampaglione, Yan Zhao, Rachel M. Huckfeldt, Kinga M. Bujakowska & Eric Pierce. (2023) Natural history of retinitis pigmentosa based on genotype, vitamin A/E supplementation, and an electroretinogram biomarker. JCI Insight 8:15.
Crossref
Weiming Ren, Suyang Duan, Chao Dai, Chunbao Xie, Lingxi Jiang & Yi Shi. (2023) Nanotechnology Lighting the Way for Gene Therapy in Ophthalmopathy: From Opportunities toward Applications. Molecules 28:8, pages 3500.
Crossref
Malena Daich Varela, Anastasios Georgiadis & Michel Michaelides. (2022) Genetic treatment for autosomal dominant inherited retinal dystrophies: approaches, challenges and targeted genotypes. British Journal of Ophthalmology, pages bjophthalmol-2022-321903.
Crossref
Hyeong-Gon Yu. 2022. Inherited Retinal Disease. Inherited Retinal Disease 69 97 .
Samuel McLenachan, Dan Zhang, Janya Grainok, Xiao Zhang, Zhiqin Huang, Shang-Chih Chen, Khine Zaw, Alanis Lima, Luke Jennings, Danial Roshandel, Sang Yoon Moon, Rachael C. Heath Jeffery, Mary S. Attia, Jennifer A. Thompson, Tina M. Lamey, Terri L. McLaren, John De Roach, Sue Fletcher & Fred K. Chen. (2021) Determinants of Disease Penetrance in PRPF31-Associated Retinopathy. Genes 12:10, pages 1542.
Crossref
Danial Roshandel, Jennifer A. Thompson, Rachael C. Heath Jeffery, Dan Zhang, Tina M. Lamey, Terri L. McLaren, John N. De Roach, Samuel McLenachan, David A. Mackey & Fred K. Chen. (2021) Clinical Evidence for the Importance of the Wild-Type PRPF31 Allele in the Phenotypic Expression of RP11. Genes 12:6, pages 915.
Crossref
Rocio Maldonado, Sami Jalil & Kirmo Wartiovaara. (2020) Curative gene therapies for rare diseases. Journal of Community Genetics 12:2, pages 267-276.
Crossref
Manlong Xu, Yi Zhai & Ian M. MacDonald. (2020) Visual Field Progression in Retinitis Pigmentosa. Investigative Opthalmology & Visual Science 61:6, pages 56.
Crossref
Gabrielle Wheway, Andrew Douglas, Diana Baralle & Elsa Guillot. (2020) Mutation spectrum of PRPF31, genotype-phenotype correlation in retinitis pigmentosa, and opportunities for therapy. Experimental Eye Research 192, pages 107950.
Crossref
Ye Tao, Lun Cai, Dawei Zhou, Chunhui Wang, Zhao Ma, Xiaofei Dong & Guanghua Peng. (2019) CoPP-Induced-Induced HO-1 Overexpression Alleviates Photoreceptor Degeneration With Rapid Dynamics: A Therapeutic Molecular Against Retinopathy. Investigative Opthalmology & Visual Science 60:15, pages 5080.
Crossref
Elizabeth M. Brydon, Revital Bronstein, Adriana Buskin, Majlinda Lako, Eric A. Pierce & Rosario Fernandez-Godino. (2019) AAV-Mediated Gene Augmentation Therapy Restores Critical Functions in Mutant PRPF31+/− iPSC-Derived RPE Cells. Molecular Therapy - Methods & Clinical Development 15, pages 392-402.
Crossref
Michalitsa Diakatou, Gaël Manes, Beatrice Bocquet, Isabelle Meunier & Vasiliki Kalatzis. (2019) Genome Editing as a Treatment for the Most Prevalent Causative Genes of Autosomal Dominant Retinitis Pigmentosa. International Journal of Molecular Sciences 20:10, pages 2542.
Crossref
Kelly Kiser, Kaylie D. Webb-Jones, Sara J. Bowne, Lori S. Sullivan, Stephen P. Daiger & David G. Birch. (2019) Time Course of Disease Progression of PRPF31-mediated Retinitis Pigmentosa. American Journal of Ophthalmology 200, pages 76-84.
Crossref
Sanne K. Verbakel, Ramon A.C. van Huet, Camiel J.F. Boon, Anneke I. den Hollander, Rob W.J. Collin, Caroline C.W. Klaver, Carel B. Hoyng, Ronald Roepman & B. Jeroen Klevering. (2018) Non-syndromic retinitis pigmentosa. Progress in Retinal and Eye Research 66, pages 157-186.
Crossref
Amir H. Hariri, Wei Gui, Ghazala A. Datoo O'Keefe, Michael S. Ip, SriniVas R. Sadda & Michael B. Gorin. (2018) Ultra-Widefield Fundus Autofluorescence Imaging of Patients with Retinitis Pigmentosa. Ophthalmology Retina 2:7, pages 735-745.
Crossref
Marina França Dias, Kwangsic Joo, Jessica A. Kemp, Silvia Ligório Fialho, Armando da Silva CunhaJr.Jr., Se Joon Woo & Young Jik Kwon. (2018) Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives. Progress in Retinal and Eye Research 63, pages 107-131.
Crossref
Kentaro Kurata, Katsuhiro Hosono & Yoshihiro Hotta. (2018) Long-term clinical course of 2 Japanese patients with PRPF31-related retinitis pigmentosa. Japanese Journal of Ophthalmology 62:2, pages 186-193.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.